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Quorum sensing is a mechanism of cell-to-cell communi-
cation that allows bacteria to coordinately regulate gene
expression in response to changes in cell-population den-
sity. At the core of the Vibrio cholerae quorum-sensing
signal transduction pathway reside four homologous small
RNAs (sRNAs), named the quorum regulatory RNAs 1–4
(Qrr1–4). The four Qrr sRNAs are functionally redundant.
That is, expression of any one of them is sufﬁcient for
wild-type quorum-sensing behaviour. Here, we show that
the combined action of two feedback loops, one involving
the sRNA-activator LuxO and one involving the sRNA-
target HapR, promotes gene dosage compensation between
the four qrr genes. Gene dosage compensation adjusts the
total Qrr1–4 sRNA pool and provides the molecular
mechanism underlying sRNA redundancy. The dosage
compensation mechanism is exquisitely sensitive to
small perturbations in Qrr levels. Precisely maintained
Qrr levels are required to direct the proper timing
and correct patterns of expression of quorum-sensing-
regulated target genes.
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Introduction
Chemical communication allows groups of bacteria to moni-
tor and synchronously alter gene expression in response to
changes in cell number and species-composition of the
surrounding bacterial community. Communication is accom-
plished through the synthesis, secretion, and subsequent
detection of signalling molecules called auto-inducers (AIs).
This process, known as quorum sensing, is used by many
bacterial species to coordinately control a battery of beha-
viours (Waters and Bassler, 2005; Bassler and Losick, 2006).
In the human pathogen Vibrio cholerae, quorum sensing
regulates progression through the infectious cycle, controls
genes encoding virulence factors, and regulates bioﬁlm for-
mation (Zhu et al, 2002; Hammer and Bassler, 2003; Zhu and
Mekalanos, 2003).
Vibrio cholerae makes and responds to two AIs that func-
tion synergistically to control group behaviours (Miller et al,
2002). At low cell-population density (LCD), when the extra-
cellular AI concentration is low, membrane-bound AI-receptors
function as kinases and phosphorylate a shared phosphotrans-
fer protein called LuxU, which subsequently transfers the
phosphate to the response regulator LuxO. LuxO-P, together
with the alternative sigma factor s
54, activates transcription of
four genes encoding small non-coding RNAs (sRNAs), called
the quorum regulatory RNAs (Qrr1–4) (Figure 1, and Miller
et al, 2002; Lenz et al, 2004). When transcribed, the Qrr sRNAs
function together with the RNA chaperone Hfq to control
translation of target mRNAs. One target mRNA, which is
destabilized by the Qrrs at LCD, encodes the major quorum-
sensing transcription factor, HapR.
At high cell-population density (HCD), AIs accumulate
extracellularly and bind their respective receptors. This
event switches the receptors’ enzymatic activity from kinase
to phosphatase, ultimately resulting in dephosphorylation of
LuxO-P. Dephosphorylated LuxO cannot activate qrr trans-
cription. Existing sRNAs are rapidly turned over, as Hfq-
dependent sRNAs are degraded stoichiometrically with their
target mRNAs (Masse et al, 2003). In the absence of Qrr
sRNAs, hapR mRNA is translated and HapR protein accumu-
lates and activates or represses its target genes. In summary,
V. cholerae cells at LCD are characterized by the presence of
Qrr sRNAs and the absence of HapR, whereas V. cholerae cells
at HCD are characterized by the absence of Qrr sRNAs and
the presence of HapR.
Small RNAs are widely used as key regulators of stress
responses, virulence, and central metabolic pathways in
bacteria (Romeo, 1998; Gottesman, 2004; Majdalani et al,
2005; Storz et al, 2005). In many cases, multiple homologous
sRNAs exist, and often they appear to carry out identical
functions (Weilbacher et al, 2003; Wilderman et al, 2004;
Guillier and Gottesman, 2006). In the case of V. cholerae
quorum sensing, the Qrr sRNAs are encoded by four unlinked
loci. They are B80% identical in sequence and predicted to
have similar secondary structures (Lenz et al, 2004). Previous
analyses of single, double, triple, and quadruple qrr deletions
in V. cholerae showed that the four Qrr sRNAs function
redundantly to control quorum sensing (Lenz et al, 2004).
That is, if any one of the four Qrr sRNAs is present,
V. cholerae expresses quorum-sensing target genes in a den-
Received: 18 October 2008; accepted: 19 December 2008; published
online: 22 January 2009
*Corresponding author. Department of Molecular Biology, HHMI
and Princeton University, 329 Lewis Thomas Labs, Princeton,
NJ 08544-1014, USA. Tel.: þ609 258 2857; Fax: þ609 258 2957;
E-mail: bbassler@princeton.edu
The EMBO Journal (2009) 28, 429–439 | & 2009 European Molecular Biology Organization|Some Rights Reserved 0261-4189/09
www.embojournal.org
&2009 European Molecular Biology Organization The EMBO Journal VOL 28 | NO 4 | 2009
 
EMBO
 
THE
EMBO
JOURNAL
THE
EMBO
JOURNAL
429sity-dependent manner similar to the wild-type strain. By
contrast, in the closely related bacterium Vibrio harveyi, the
analogous multiple Qrr sRNAs contribute additively to con-
trol quorum sensing (Tu and Bassler, 2007).
Two feedback loops have been described in the V. cholerae
regulatory network, which appear, ﬁrst, to ensure the net-
work’s exquisite responsiveness to changes in extracellular
AI concentrations, and second, to set the AI concentration
thresholds at which quorum-sensing-regulated behaviours
are initiated or terminated. The two feedback loops are as
follows.
HapR auto-repression loop
The HapR protein binds to a site immediately downstream
of the hapR transcriptional start site and, in this capacity,
represses its own transcription (Figure 1, HapR auto-repres-
sion loop) (Lin et al, 2005). At HCD, HapR accumulates to a
level sufﬁcient to regulate its target genes, but because it also
binds to its own promoter, it prevents additional hapR
transcription, and thereby prevents excessive accumulation
of HapR. HapR auto-repression is essential for the proper
timing of the quorum-sensing response because the HapR
pool must be maintained at a low enough level that HapR can
be efﬁciently eliminated when V. cholerae switches from the
HCD to the LCD gene expression pattern (Lin et al, 2005;
Svenningsen et al, 2008).
HapR-Qrr feedback loop
HapR enhances transcription of the four qrr genes (Figure 1,
HapR-Qrr feedback loop). However, because there is also an
absolute requirement for LuxO-P to initiate qrr transcription,
the HapR-Qrr feedback loop only functions when V. cholerae
cells shift from the HCD to the LCD condition (Svenningsen
et al, 2008). At this transition, the HapR-Qrr feedback pro-
vides a surge in qrr transcription, which accelerates the
alterations in gene expression required for the V. cholerae
LCD lifestyle.
Here, we investigate the mechanism underlying Qrr re-
dundancy and we ﬁnd that the Qrr sRNAs compensate for
one another. Speciﬁcally, in the absence of any one Qrr, the
other Qrrs are upregulated. The combination of two feedback
loops, the HapR-Qrr feedback loop described above, and a
new feedback loop described in this work, the LuxO-Qrr
feedback loop, underlies Qrr dosage compensation.
Together, these feedback loops provide a mechanism for
adjusting qrr transcription on the basis of the total activity
of the Qrr sRNAs present in a cell at any given time.
Remarkably, the Qrr dosage compensation mechanism is
able to respond to modest, that is, physiologically relevant,
alterations in Qrr levels. Calibration of the Qrr sRNA levels
through dosage compensation ensures precise timing of the
activation and termination of quorum-sensing-controlled be-
haviours.
Results
The four Qrr sRNAs compensate for one another
Our previous results showed that all four qrr sRNAs have
redundant functions in quorum sensing: any one of them is
sufﬁcient for cell-density-dependent expression of HapR-con-
trolled target genes (Lenz et al, 2004). We wondered how any
one Qrr sRNA could be sufﬁcient for an approximately wild-
type quorum-sensing response. One possibility is that, in the
absence of a particular sRNA, the levels of the remaining
sRNAs increase. To test this possibility, we used northern
blots to measure the levels of each individual Qrr sRNA in the
wild-type strain and in triple qrr deletion strains lacking the
other three qrr genes (Figure 2A). Each row shows a blot
probed speciﬁcally for the Qrr sRNA indicated on the right.
For example, results for Qrr1 are shown in the top row. Lane 1
contains total RNA from the wild-type strain, and lane 2
contains the same amount of total RNA from the triple
Dqrr2,3,4 deletion strain. It is evident that greater Qrr1 is
present in the absence of the other three Qrr sRNAs, than in
their presence. The same pattern holds true for Qrr2, Qrr3,
and Qrr4. As a control, lane 3 of each row contains total RNA
from a V. cholerae mutant deleted for only the Qrr sRNA being
probed. This lane shows that the Qrr1, Qrr2, and Qrr4 probes
are speciﬁc for their particular sRNAs and do not cross-
hybridize. Weak cross-hybridization occurs with the Qrr3
probe; however, this low level of cross-hybridization does
not affect the interpretation of the results.
Dosage compensation functions at the level of qrr
transcription
The increased abundance of one Qrr sRNA in the absence of
the other Qrr sRNAs could be the result of increased tran-
scription of the qrr gene in question, increased stability of the
Qrr sRNA, or both. If transcription of one qrr gene increases
in the absence of the other Qrr sRNAs, we reasoned that a
transcriptional reporter fusion would reﬂect this. By contrast,
regulation at the level of sRNA stability would not be
Qrr sRNAs
LuxO-P
HapR
Quorum sensing 
target genes
HapR auto-repression loop
LuxO auto-repression loop
HapR-Qrr feedback loop
LuxO-Qrr feedback loop
Hfq
Hfq
X
Auto-inducer inputs
LuxO-P
Qrr sRNAs
HapR
Quorum-sensing
target genes
σ54
Figure 1 Model of the core of the V. cholerae quorum-sensing
circuit. The backbone of the quorum-sensing signalling pathway
is depicted in black. Auto-inducer inputs are ultimately transmitted
to LuxO. At LCD, LuxO-P functions together with s
54 to activate
transcription of the genes encoding the four Qrr sRNAs. The Qrr
sRNAs, in conjunction with Hfq, repress translation of hapR mRNA.
When hapR translation is derepressed, HapR controls downstream
target genes. The previously deﬁned feedback loops are shown in
blue. HapR and LuxO auto-repress the hapR and luxO promoters,
respectively (see discussion for details on the LuxO auto-repression
loop). HapR also enhances qrr transcription through an unknown
factor, denoted by ‘X’. The feedback loop between the Qrr sRNAs
and LuxO identiﬁed in this work is shown in red. Arrows indicate
positive interactions, T-bars indicate negative interactions.
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gineered lux reporter fusions to the þ1 transcriptional start
sites of each qrr gene (Svenningsen et al, 2008). Expression of
the lux fusions in the wild-type and the Dqrr1–4 strains was
measured at OD600¼0.1, the cell density at which the Qrr
sRNAs are maximally produced (Svenningsen et al, 2008),
and the results are shown in Table I. Expression of each qrr
gene is higher in the Dqrr1–4 mutant than in the wild type.
Thus, dosage compensation occurs at the level of qrr trans-
cription. We note that dosage compensation affects the four
qrr promoters to different extents (see ‘Fold Repression’,
Table I). We return to this point later.
In addition to transcriptional control, dosage compensa-
tion could also be a consequence of regulation of sRNA
stability. To examine this possibility, we needed to uncouple
regulation at the transcriptional level from regulation at the
post-transcriptional level. To do this, we expressed the qrr4
gene from an exogenous Ptac promoter in Dqrr4 and Dqrr1–4
strains and measured Qrr4 levels by Northern blot
(Figure 2B). Qrr4 driven by the Ptac promoter accumulates
to identical levels in the presence and absence of the other qrr
genes, indicating that the Ptac-qrr4 construct is not sensitive
to alterations in sRNA levels. Thus, we conclude that, at least
for qrr4, and presume for the other qrr genes, dosage com-
pensation stems from transcriptional control, and not from
the regulation of sRNA stability.
Dosage compensation is independent of the origin
of the Qrr sRNAs
We considered two possible mechanisms that could give rise
to the Qrr dosage compensation observed above. First, Qrr
dosage compensation could be a regulatory element wired
into the quorum-sensing network, that is, a Qrr-responsive
negative feedback loop that represses the qrr promoters could
exist. In this scenario, any shortage in Qrr sRNAs would
result in reduced repression of the qrr promoters, leading to a
compensatory increase in Qrr sRNA production. Second,
dosage compensation could be an incidental consequence
of titration of a transcription factor(s) required for expression
of the qrr promoters. In this scenario, in the absence of one or
more qrr genes, increased levels of this putative transcription
factor(s) would be available to bind and activate the expres-
sion of the remaining qrr promoters. In the ﬁrst case, an
exogenously provided source of Qrr sRNA would cause
repression of qrr transcription. In the second case, only Qrr
sRNAs made from endogenous qrr promoters would cause
repression of qrr transcription.
To test which mechanism is correct, we measured light
production from the qrr–lux promoter fusions in the absence
of Qrr sRNAs (Figure 3, white bars), in the presence of Qrr
sRNAs produced from their endogenous promoters (Figure 3,
black bars), Qrr4 sRNA produced from a plasmid-borne
endogenous qrr4 promoter (Figure 3, striped bars), and
Qrr4 sRNA produced from a plasmid carrying the exogenous
Ptac promoter, which, besides core RNA polymerase, shares
no transcription factors with those required for native
qrr expression (Figure 3, dotted bars). The ﬁgure shows
that Qrr sRNAs produced from any source cause repression
of the qrr–lux promoter fusions. Thus, dosage compensation
must be a result of negative feedback control of qrr expres-
sion by the Qrr sRNAs themselves, and not due to titration of
factors required for qrr transcription.
The HapR-Qrr feedback loop is partially responsible
for Qrr dosage compensation
On the basis of the above results, we hypothesize that the Qrr
sRNAs compensate for one another by controlling the trans-
lation of a transcription factor, which in turn feeds back to
regulate qrr gene expression. As described in the
Introduction, one obvious candidate is the HapR-Qrr feed-
back loop identiﬁed previously (Svenningsen et al, 2008,
Figure 1; HapR-Qrr feedback loop). We reason that if there
is a shortage of Qrr sRNAs, increased HapR could be
Table I Dosage compensation acts at the level of transcription
of the qrr genes
qrr1-lux
a qrr2-lux
a qrr3-lux
a qrr4-lux
a
Wild type 56 (3) 140 (20) 7 (3) 74 (15)
Dqrr1-4 149 (3) 373 (28) 159 (5) 378 (26)
Fold repression
b 2.7 (0.05) 2.7 (0.16) 24 (0.39) 5.1 (0.22)
DhapR 28 (1) 154 (28) 6 (1) 47 (30)
DhapR Dqrr1–4 34 (1) 226 (55) 29 (10) 179 (52)
Fold repression
b 1.2 (0.04) 1.5 (0.30) 4.8 (0.35) 3.8 (0.69)
aLight production from the indicated qrr–lux construct was mea-
sured at OD600¼0.1 in the indicated V. cholerae strains. The average
relative light units (RLU/10
8) from three independent cultures is
reported. The standard error from the mean (RLU/10
8) is indicated
in parentheses.
bFold repression is calculated as the light produced by the Dqrr1–4
mutant divided by the light produced by the isogenic qrr1–4
+
strain.
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Figure 2 Qrr sRNA levels in wild-type and triple qrr deletion
strains. (A) Northern blots showing Qrr levels in wild-type
V. cholerae (lane 1), V. cholerae qrr triple deletion strains, possessing
only the qrr gene encoding the sRNA indicated on the right (lane 2),
and V. cholerae qrr single deletion strains, lacking only the qrr gene
encoding the Qrr sRNA indicated on the right (lane 3). Total RNA
was visualized with ethidium bromide as the loading control (not
shown). (B) Northern blot showing Qrr4 levels in a V. cholerae qrr4
single deletion strain expressing qrr4 from the Ptac promoter
(lane 1) and a V. cholerae Dqrr1–4 quadruple deletion expressing
qrr4 from the Ptac promoter (lane 2). 5S RNA is shown as a loading
control. Total RNA was collected from the indicated strains at
OD600¼0.1.
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of Qrr sRNAs, resulting in Qrr dosage compensation.
To test if the HapR-Qrr feedback loop is required for Qrr
dosage compensation, we compared qrr–lux light production
in a DhapR V. cholerae strain with that in a DhapR, Dqrr1–4
strain (Table I). Our rationale is that if the HapR-Qrr feedback
loop is responsible for Qrr dosage compensation, dosage
compensation will not occur in the DhapR strains because
any feedback loop requiring HapR will not be functioning in
the DhapR strains. Indeed, when compared with the wild-
type strain background, the extent of dosage compensation is
reduced for all four qrr promoters in the DhapR strain back-
grounds (Table I, ‘Fold Repression’), suggesting that the
HapR-Qrr feedback loop is involved in dosage compensation.
However, whereas removal of the HapR-Qrr feedback loop
nearly eliminated dosage compensation for qrr1 and qrr2,
dosage compensation at qrr3 and qrr4 continued to occur in
the DhapR strains. Thus, qrr1 and qrr2, which are the least
subject to dosage compensation in wild-type V. cholerae
(Table I), require the HapR-Qrr feedback loop for dosage
compensation. By contrast, qrr3 and qrr4, which show a
greater degree of dosage compensation, although obviously
regulated by the HapR-Qrr feedback loop, must also respond
to an additional regulatory component(s) for dosage com-
pensation.
luxOU mRNA is a target of Qrr sRNA regulation
To identify the additional regulatory component involved in
qrr3 and qrr4 dosage compensation, we relied on our ﬁndings
in V. harveyi, which is closely related to V. cholerae and has a
similar quorum-sensing circuit. In V. harveyi, the Qrr sRNAs
repress translation of LuxO (Tu et al, manuscript in prepar-
ation). Thus, we wondered if the Qrr sRNAs might feed back
to regulate luxO translation as part of the dosage compensa-
tion mechanism in V. cholerae. Alignment of the 50-untrans-
lated region (50-UTR) of V. cholerae luxO and the two known
targets of Qrr1–4, hapR and vca0939, showed that the 50-UTR
of the poly-cistronic luxOU mRNA contains a region of
complementarity to the Qrr sRNAs similar to that predicted
in the hapR and vca0939 50-UTRs (Figure 4A, and Tu et al,
manuscript in preparation, Lenz et al, 2004; Hammer and
Bassler, 2007).
To test if the Qrr sRNAs feed back to regulate luxOU mRNA
in V. cholerae, we assayed the stability of luxOU mRNA using
northern blots. Rifampicin was added to LCD V. cholerae
cultures to terminate transcription, after which the level of
luxOU mRNA transcript was monitored over time
(Figure 4B). In wild-type cells (denoted by WT), luxOU
mRNA is degraded with a half-life of B94s following termi-
nation of transcription. In the Dqrr1–4 strain, the stability of
the luxOU mRNA is increased, (half-life¼B115s). By con-
trast, in a V. cholerae strain that overexpresses Qrr4 (denoted
by Dqrr1–4 Ptac-qrr4), the half-life of luxOU mRNA is re-
duced to B35s, supporting the idea that Qrr1–4 destabilize
luxOU mRNA.
To measure the consequence of Qrr sRNA-mediated degra-
dation of the luxOU mRNA on LuxO levels, we engineered a
translational fusion of the luxO 50-UTR including the ﬁrst 10
amino acids of the LuxO ORF to green ﬂuorescent protein
(GFP). We introduced the plasmid-borne LuxO–GFP fusion
into Escherichia coli strain SLS1277, which expresses
V. cholerae qrr4 from the chromosome, under control of the
PBAD promoter. Figure 4C (left bars) shows the production of
LuxO–GFP in SLS1277 without or with induction of Qrr4
synthesis by the addition of arabinose. LuxO–GFP expression
is repressed B4-fold by Qrr4, suggesting that the Qrr sRNAs
repress translation of luxOU mRNA.
The LuxO-Qrr feedback loop is partially responsible
for Qrr dosage compensation
The results presented in Figure 4 suggest that Qrr repression
of luxO could aid in Qrr dosage compensation because
reduced Qrr sRNA levels could lead to increased LuxO
production, which in turn could result in increased Qrr
sRNA production (Figure 1, LuxO-Qrr feedback loop).
To explore this idea, we engineered mutations in the luxO
50-UTR that prevent pairing between the luxOU mRNA and
the Qrr sRNAs. The predicted region of pairing overlaps the
ribosome binding site of luxO, so most nucleotide changes in
this region alter the basal level of luxO expression (data not
shown). One mutation, however, luxO
AUCC, nearly eliminates
Qrr-mediated repression of luxO (Figure 4C, right pair of
bars), without signiﬁcantly changing the basal expression
level of luxO (Figure 4C, compare the two black bars). In this
mutant, nucleotides  6t o 3 (TAGG) with respect to the ﬁrst
nucleotide in the luxO start codon were mutated to the
complementary sequence (ATCC). The mutated sequence is
underlined in Figure 4A. In Figure 5, we compare the extent
of Qrr dosage compensation in the wild-type (black bars), the
DhapR strain lacking the HapR-Qrr feedback loop (white
bars), the luxO
AUCC strain, which lacks the LuxO-Qrr feed-
back loop (grey bars), and the DhapR, luxO
AUCC double
mutant, which lacks both feedback loops (striped bars). Qrr
dosage compensation was measured as the fold repression of
R
L
U
Reporter fusion
1010
1011
109
108
qrr4–lux qrr3–lux qrr2–lux qrr1–lux
Wild type, pVector
Δqrr1-4, Pqrr4-qrr4
Δqrr1-4, Ptac-qrr4
Δqrr1-4, pVector
Figure 3 Dosage compensation is insensitive to the origin of the
Qrr sRNAs. Light production from the indicated qrr–lux constructs
was measured at OD600¼0.1 in a V. cholerae Dqrr1–4 mutant
carrying the vector (white bars), V. cholerae wild type carrying
the vector (black bars), a V. cholerae Dqrr1–4 mutant expressing
qrr4 under control of the endogenous qrr4 promoter on the vector
(striped bars), and a Dqrr1–4 mutant expressing qrr4 under control
of the Ptac promoter on the same vector (dotted bars). Each bar
shows the average light production from three independent
cultures. Error bars indicate one standard deviation from the
mean. RLU: relative light units.
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þ strain
compared with that in the isogenic Dqrr1–4 strain.
For reference, we show again that the HapR-Qrr feedback
loop is involved in dosage compensation (compare white
bars with black bars). The luxO
AUCC mutation partially elim-
inates dosage compensation for each qrr gene (compare grey
bars with black bars), showing that indeed the LuxO-Qrr
feedback loop contributes to Qrr dosage compensation.
However, we note that the two feedback loops contribute
distinctly to dosage compensation of each qrr gene. Dosage
compensation in the case of qrr1 and qrr2 is largely due to the
HapR-Qrr feedback loop. By contrast, the Qrr-LuxO feedback
loop is the major source of dosage compensation for qrr4. In
all three of these cases, simultaneous disruption of the HapR-
Qrr and LuxO-Qrr feedback loops completely eliminates
dosage compensation (compare striped bars with black
bars). These results show that for qrr1, qrr2, and qrr4, the
two feedback loops are sufﬁcient to account for dosage
compensation. Remarkably, qrr3, although clearly regulated
by the two feedback loops, remains responsive to dosage
compensation in the absence of both the HapR-Qrr and the
LuxO-Qrr feedback loops. We interpret this to mean that an
additional feedback loop, which is involved in dosage com-
pensation, exists that has yet to be identiﬁed. This feedback
loop is apparently speciﬁc to qrr3.
Determining the boundaries of Qrr dosage
compensation
The Qrr sRNAs constitute the core of the quorum-sensing
regulatory cascade, and regulation by them ultimately dic-
tates the expression patterns of all downstream quorum-
sensing target genes. Thus, we predict that keeping Qrr levels
tightly constrained is a priority for this regulatory network. To
investigate this idea, we examined the accuracy of Qrr dosage
compensation in the quorum-sensing circuit. We made one
assumption; that the four Qrr sRNAs are equally effective in
pairing with their target mRNAs. If so, accurate dosage
compensation should result in an identical total Qrr sRNA
Qrr sRNAs (reverse complement)
hapR mRNA
vca0939 mRNA
luxOU mRNA
UUCACUAACAACGUCAGUUGGCUAGGUGACCC
UCAAUCAACAAC-UCAAUUGGCAAGGAUAUAC
UUUAAAAAUAACG--A-UUGGCUAGGUUCCCC
GCAAAAUGCAAAAUAAUAUGGCUAGGCUAUGC
A UUCACUAACAACGUCAGUUGGCUAGGUGACCC
UCAAUCAACAAC-UCAAUUGGCAAGGAUAUAC
UUUAAAAAUAACG--A-UUGGCUAGGUUCCCC
GCAAAAUGCAAAAUAAUAUGGCUAGGCUAUGC
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Figure 4 luxOU mRNA is a target of Qrr sRNA translational repression. (A) Alignment of the reverse complement of the conserved pairing
region of the Qrr sRNAs with the 50-UTRof two known target mRNAs, hapR and vca0939, and the 50-UTRof luxOU mRNA. The region of the Qrr
sRNAs that pair with the hapR and vca0939 50-UTRs is completely conserved among the four Qrrs. Nucleotides in the target mRNAs that are
complementary to the Qrr sRNAs are highlighted in white on black background. The underlined sequence (UAGG) of luxOU mRNA is mutated
to AUCC in the luxO
AUCC mutant. (B) Degradation of the luxOU mRNA was measured by northern blot in V. cholerae wild-type, Dqrr1–4 and
Dqrr1–4, Ptac-qrr4 following transcription termination. The indicated times are seconds after addition of rifampicin. 5S RNA is shown as a
loading control. (C) E. coli SLS1277 carrying plasmids harbouring either LuxO–GFP (pSLS146) or LuxO
AUCC–GFP (pSLS152) protein fusions
were grown overnight in either LB (black bars) or LB supplemented with 0.4% arabinose (white bars). The experiment was performed in
duplicate on three separate occasions. Error bars indicate one standard deviation from the mean of all six measurements.
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the contribution of a particular sRNA following deletion
should be compensated for by overexpression of the remain-
ing Qrr sRNAs. To survey a range of altered Qrr levels, we
examined Qrr dosage compensation accuracy in response to a
large perturbation in qrr gene dosage by deleting all combi-
nations of three qrr genes, as well as more modest changes
in gene dosage by sequentially deleting individual qrr genes.
Dosage compensation is inaccurate in triple qrr mutant
strains. To measure the total Qrr sRNA pool, we performed
northern blots with a probe complementary to the 32bp
region that is 100% conserved among the four Qrr sRNAs.
This probe binds the four Qrr sRNAs indiscriminately as
conﬁrmed using known concentrations of each Qrr trans-
cribed in vitro (data not shown). Figure 6A shows the total
Qrr sRNAs in wild type and the four qrr triple mutant strains.
All the triple mutant strains, especially the qrr1
þ mutant,
contain markedly less total Qrr sRNAs than does the wild-
type strain. This ﬁnding indicates that Qrr dosage compensa-
tion is not accurate in the qrr triple mutants.
We were surprised that dosage compensation is not exact
in the qrr triple mutants, because all four qrr triple mutants
appear to have wild-type quorum-sensing behaviour, as
measured by the cell-density-dependent expression of quor-
um-sensing reporters (Lenz et al, 2004). We wondered
whether our earlier measurements of the ﬁnal quorum-sen-
sing output behaviour are too far downstream in the quorum-
sensing cascade to accurately reﬂect Qrr activities. To exam-
ine the effect of the depletion of the Qrr sRNAs on their
immediate quorum-sensing target, we measured hapR mRNA
levels in wild type and the same triple qrr mutants shown in
Figure 6A by quantitative real-time PCR. The level of hapR
mRNA in wild-type cells is set to 1. Figure 6B shows that, in
the qrr4
þ triple-mutant strain, hapR mRNA levels are as low
as in wild type; however, in the three other triple mutant
strains, in which only qrr1, qrr2, or qrr3 is present, hapR
mRNA levels are higher than in wild type. For comparison,
we show that in the Dqrr1–4 mutant strain, derepressed hapR
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is the most abundant of the Qrrs (Lenz et al, 2004; Lenz and
Bassler, 2007), and apparently it alone is sufﬁcient to cor-
rectly regulate hapR mRNA levels (Figure 6B). This is not the
case, however, for the less abundant Qrrs 1, 2, and 3. We
conclude that there is an upper limit to the extent to which
the quorum-sensing cascade can tolerate and compensate for
changes that deplete the Qrr sRNA pool in V. cholerae. Even
so, we note that hapR mRNA is repressed extensively in all
the triple qrr mutants compared with the Dqrr1–4 mutant.
This ﬁnding apparently explains their wild-type-like quorum-
sensing phenotypes.
Dosage compensation is sensitive to small perturbations
in Qrr levels. The above results show that, in a qrr triple
deletion mutant, although production of the remaining Qrr
sRNA is increased compared with its expression in wild-type
V. cholerae (Figure 2A), dosage compensation is not espe-
cially accurate except in the case of Qrr4 (Figure 6B). We
hypothesize that the variations in Qrr levels that V. cholerae
experiences in its natural habitats, and thus the variations
that the quorum-sensing dosage compensation mechanism is
tuned to detect and respond to, are more modest than the
extreme variations in gene dose caused by triple deletion of
the qrr genes. To test if this is so, we assayed dosage
compensation following small alterations in Qrr levels, by
sequential removal of only one of the four qrr genes.
Speciﬁcally, we measured Qrr4 levels in wild-type (WT),
single (Dqrr3), double (Dqrr2,3), and triple (Dqrr1,2,3) qrr
mutants by northern blot. We engineered the set of mutants
to retain qrr4 because, as mentioned, Qrr4 is the most
abundant Qrr sRNA in wild-type V. cholerae, and hence
sequential deletion of qrr1, qrr2, and qrr3 while keeping
qrr4 intact causes the least perturbation to the Qrr pool.
Figure 7A shows that indeed Qrr4 levels increase with
increasing deletions of qrr genes, indicating that qrr4 dosage
compensation is sensitive to the loss of any one of the other
qrr genes. To examine the sensitivity of dosage compensation
at the other qrr promoters, we quantiﬁed the level of each of
the individual Qrr sRNAs in the wild-type, single, double, and
triple qrr mutant strains (Figure 7B). The level of each RNA
species in the wild type is set to 1 (green bars). In the Dqrr3
single mutant strain, each of the remaining Qrr sRNA levels is
higher than in the wild type (compare pink bars with green
bars). In the Dqrr2,3 double-mutant strain, levels of the two
remaining Qrrs are even higher (compare yellow bars with
pink bars). Finally, in the Dqrr1,2,3 triple-mutant strain, Qrr4
is at the highest level (compare blue bar with yellow bar).
Thus, each qrr promoter is sensitive to the deletion of any
single qrr gene.
The ﬁgure shows that sequential deletion of qrr genes
apparently triggers the production of sufﬁcient remaining
Qrr sRNA to provide wild-type-like repression of hapR
mRNA levels (right group of bars). This result could indicate
that the dosage compensation mechanism is exquisitely
accurate, that is, that the exact amount of the remaining
Qrr sRNAs is synthesized to repress hapR mRNA to exactly
wild-type levels. Alternatively, an additional factor required
for hapR mRNA degradation could be limiting. In this scenar-
io, the hapR mRNA level present in wild-type cells at LCD is
the lowest hapR level achievable by excess production of the
Qrr sRNAs. To test this latter possibility, we examined hapR
mRNA levels in a V. cholerae Dqrr1–4 strain overexpressing
qrr4 from the Ptac promoter. This construct is not sensitive to
dosage compensation (see Figure 2B). We reasoned that, if
Qrr-mediated repression of hapR mRNA is not limited by
some other factor, hapR mRNA levels should decrease in the
Qrr4 overexpression strain. Figure 7B shows that Qrr4 levels
in this strain are B250-fold higher than in wild type (see Qrr4
and compare black bar with green bar). Nonetheless, hapR
mRNA levels in this strain are essentially identical to wild
type (see hapR, compare black bar with green bar). Thus,
Qrr-mediated hapR mRNA degradation operates at its full
capacity in wild-type V. cholerae cells at LCD, and production
of additional Qrr sRNAs does not increase hapR mRNA
degradation.
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Figure 7 Dosage compensation is sensitive to the loss of any
individual qrr gene. (A) Northern blot showing Qrr4 levels in
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present, the hapR mRNA level cannot decrease to below that
present in wild-type cells. We wondered what happens to
HapR protein levels following overproduction of Qrr sRNAs.
To examine this, we determined HapR levels in the same
V. cholerae strains shown in Figure 7B. At LCD (OD600¼0.1,
Figure 7C top panel), HapR levels are only slightly elevated in
the three qrr mutants compared with wild type. This result
suggests that sufﬁcient Qrr sRNAs are produced by dosage
compensation in the qrr mutants to promote wild-type-like
repression of HapR synthesis. Importantly, HapR protein
levels are at the lowest level in both the V. cholerae wild-
type (WT) and the Ptac-qrr4 overexpression strain (Dqrr1–4,
Ptac-qrr4) conﬁrming that HapR synthesis is maximally
repressed in the V. cholerae wild-type strain at LCD, and
that additional Qrr sRNAs do not cause further repression of
HapR synthesis. Thus, provided that the Qrr levels are not
limiting for repression, exact compensation of the Qrr sRNA
pool is not required for wild-type-like hapR repression at
LCD.
Precise calibration of total Qrr levels, although apparently
not important at LCD because HapR is fully repressed, could
be critical for the timely termination of individual behaviours
and initiation of group behaviours as V. cholerae transitions
from LCD to HCD conditions. To address this hypothesis, we
examined HapR levels in the same set of V. cholerae strains
shown in Figure 7B, at an intermediate cell density
(OD600¼0.4, Figure 7C, bottom panel). HapR levels are
similar in the wild-type and the dosage-compensated single
(Dqrr3), double (Dqrr2,3), and triple (Dqrr1,2,3) qrr mutant
strains at intermediate cell density. Notably, this level of
HapR protein is higher than that in the Dqrr1–4, Ptac-qrr4
strain, showing that HapR remains fully repressed in the non-
dosage-compensated qrr4 overexpression strain (Dqrr1–4,
Ptac-qrr4). Thus, during the quorum-sensing transition,
sequential deletion of qrr genes triggers the production
of almost exactly the amount of the remaining Qrr sRNAs
required to provide wild-type, that is, accurate, repression of
HapR. We conclude that, in response to small perturbations
in Qrr levels, the Qrr sRNAs are precisely controlled by
dosage compensation in V. cholerae, and thus calibrated to
provide quite accurate quorum-sensing behaviour.
Discussion
Cell-population density, which is monitored through quorum
sensing, is among the key parameters that regulate progres-
sion through the V. cholerae infectious cycle (Zhu and
Mekalanos, 2003). Among the known targets of quorum
sensing are cholera toxin (ctxA) and the toxin-co-regulated
pilus (tcpP), virulence factors required for colonization of the
host intestinal lining and induction of the severe diarrhoea
characteristic of V. cholerae infection (Miller et al, 2002; Zhu
et al, 2002), the vps operon required for bioﬁlm formation
(Hammer and Bassler, 2003), and hapA, a protease needed
for detachment of individual cells from HCD bioﬁlms (Jobling
and Holmes, 1997). Thus, not surprisingly, a DluxO
V. cholerae strain, which is incapable of quorum sensing, is
avirulent in an infant mouse model (Miller et al, 2002). Four
homologous sRNAs, Qrr1–4, constitute the signalling-hub of
the quorum-sensing network. Input information about the
surrounding microbial community and the metabolic state of
the cell is combined to control the expression of qrr1–4, and,
in response, quorum-sensing-regulated behaviours are in-
itiated or terminated by Qrr sRNA regulation of target
mRNAs (Lenz et al, 2004). Hence, the expression patterns
of qrr1–4 determine the precise cell-population densities
at which quorum-sensing target genes are activated or
repressed. Therefore, expression of qrr1–4 must be tightly
controlled to obtain proper timing of quorum-sensing transi-
tions.
Here, we report the identiﬁcation of a new target of the Qrr
sRNAs and a negative feedback loop that assists in the
regulation of Qrr levels. The new sRNA target, luxOU
mRNA, and a previously described Qrr sRNA target, hapR
mRNA, are destabilized upon pairing with the Qrr sRNAs,
and thus LuxO and HapR production are repressed by the Qrr
sRNAs. Additionally, LuxO and HapR are both activators of
qrr transcription. This regulatory arrangement generates two
feedback loops, the LuxO-Qrr feedback loop and the HapR-
Qrr feedback loop, which together enable ﬁne-tuning of Qrr
levels (Figure 1). The abundance of the Qrr sRNAs in wild-
type V. cholerae is Qrr44Qrr2EQrr34Qrr1 (Lenz et al, 2004;
Lenz and Bassler, 2007). We show that deletion of any one of
the three least abundant Qrr sRNAs (qrr1, 2, or 3) elicits a
compensatory increase in the remaining sRNAs that is sufﬁ-
cient to maintain wild-type-like repression of a target (hapR)
mRNA at LCD. Interestingly, dosage compensation promotes
the identical, wild-type-like, degradation of hapR mRNA in
these mutants, but slight differences among the mutants can
be observed at the level of HapR protein accumulation. This
ﬁnding indicates that, beyond promoting degradation of the
hapR mRNA, the Qrrs could have an additional function in
blocking hapR translation. This is consistent with the obser-
vation that other Hfq-dependent sRNAs function primarily to
inhibit translation of target mRNAs, with the destabilization
of the mRNA being a secondary effect of the inhibition of
translation (Morita et al, 2006; Aiba, 2007).
Overexpression of a Qrr sRNA at LCD does not facilitate
degradation of hapR mRNA beyond what occurs in wild-type
cells at LCD, suggesting that in wild-type V. cholerae, the Qrr
sRNAs are not the limiting component for hapR mRNA
degradation at LCD. Rather, we hypothesize that an addi-
tional factor required for sRNA-mediated hapR mRNA decay
limits the rate of hapR mRNA degradation. Most likely
candidates for this limiting factor are the RNA chaperone
Hfq, which is required for Qrr repression of hapR mRNA, or
the endonuclease RNase E, which is often involved in sRNA-
mediated mRNA decay (Masse et al, 2003; Aiba, 2007). This
result implies that above a certain Qrr-threshold, precise
regulation of the Qrr pool is not required for wild-type-like
hapR repression at LCD. By contrast, we show that Qrr levels
must be kept precisely in balance to relieve repression of
HapR synthesis in a timely manner, as V. cholerae transitions
from LCD to HCD. This allows HapR to direct the appropriate
pattern of expression of quorum-sensing-regulated target
genes.
The best-known example of gene dosage compensation in
bacteria involves the ribosomal RNA (rRNA) operons of
E. coli. E. coli contains seven copies of the rRNA operon.
Increasing or decreasing the number of these operons does
not alter the total level of cellular rRNA, due to gene dosage
compensation (Jinks-Robertson et al, 1983; Condon et al,
1993). The exact mechanism of dosage compensation is not
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assembled into translation-capable ribosomes to feed back to
the rRNA genes (Cole et al, 1987). Similarly, we show here
that Qrr dosage compensation requires functional Qrr sRNAs
because the dosage compensation mechanism relies on reg-
ulation of target mRNAs by the Qrr sRNAs. This ensures that
dosage compensation is based on sRNA activity, and, as
a consequence, only functional copies of the sRNAs are
accounted for by the dosage compensation mechanism.
An additional consequence of activity-based dosage compen-
sation is that it allows for differences in the potency of the
four Qrr sRNAs. If, for example, Qrr1 is the least potent sRNA
repressor (i.e., Qrr1 binds target mRNAs with the lowest
afﬁnity), then a higher concentration of Qrr1 than the other
Qrr sRNAs is required to repress a particular target mRNA
pool. Therefore, a qrr1 deletion should be compensated for by
a sub-stoichiometric increase in the remaining Qrrs. We
suspect that differences in sRNA repressor potency explain
why the total levels of Qrr sRNAs in the qrr triple mutants in
Figure 6A do not correspond directly to the degree of repres-
sion of hapR mRNA shown in Figure 6B.
What advantage do two, rather than one, negative feed-
back loops provide to Qrr dosage compensation? We suggest
that the individual feedback loops operate under different
regimes, as LuxO-P and HapR are maximally produced at
different cell densities. HapR is produced only at HCD and
therefore affects only qrr transcription following the transi-
tion from HCD to LCD conditions (Svenningsen et al, 2008).
Hence, the HapR-Qrr feedback loop most likely does not
contribute to Qrr dosage compensation under conditions in
which V. cholerae is consistently at LCD. LuxO-P, on the other
hand, is present only at LCD and could mediate Qrr dosage
compensation under this condition. Thus, using two negative
feedback loops increases the adaptability of the dosage
compensation mechanism to different conditions. The puta-
tive third negative feedback loop (Figure 5) could increase the
plasticity of the dosage compensation mechanism even
further.
Interestingly, the wiring of the regulatory feedback loops
described here results in calibration of the total level of Qrr
activity, rather than calibration of a speciﬁc level of the
individual Qrr sRNAs. This design suggests that the com-
bined activity of the Qrr sRNAs, and not their individual
contributions, is the critical parameter that V. cholerae moni-
tors to ensure proper timing of quorum-sensing-regulated
behaviours. Supporting this observation is our ﬁnding that
all four Qrr sRNAs each regulate the three known Qrr
targets—luxO, hapR, and vca0939 (encoding a GGDEF
enzyme)—and no functions exclusive to one or a subset of
the four Qrr sRNAs have been identiﬁed (Lenz et al, 2004;
Hammer and Bassler, 2007). However, our ﬁnding that the
four qrr promoters are affected to different extents by each
individual feedback loop (Figure 5) could indicate that there
exist conditions in which it is beneﬁcial for V. cholerae to
exclusively increase the expression of one particular Qrr
sRNA.
There exists an upper bound to the functioning of the
dosage compensation mechanism: in triple qrr mutant strains
where qrr4 is among the deleted qrr genes, whereas the
remaining qrr gene is upregulated, its promoter is not acti-
vated strongly enough to completely compensate for the lack
of the other three qrr genes. Consistent with this, we ﬁnd that
hapR mRNA is not fully repressed under this condition. We
reason that this constraint on the functioning of the dosage
compensation mechanism is due to LuxO auto-repression. In
V. harveyi, LuxO represses its own expression, irrespective of
its phosphorylation state, by binding to a site overlapping the
 35 sequence of the luxO promoter, thereby preventing RNA
polymerase from initiating transcription (Tu et al, manuscript
in preparation). The LuxO-binding site and the  35 box are
completely conserved in V. cholerae, suggesting that LuxO
auto-repression functions equivalently in this organism
(Figure 1, LuxO auto-repression loop). As LuxO represses
its own promoter, LuxO can only accumulate to within a
conﬁned range even in the absence of Qrr-mediated repre-
ssion. Therefore, the qrr promoters for which LuxO has the
lowest afﬁnity do not become fully activated in the triple qrr
mutants. We suspect that the limits to dosage compensation
measured by deletion of three of the four qrr genes are not
relevant for wild-type V. cholerae. Rather, our measurements
of Qrr levels following more minor alterations in gene dosage
(Figure 7) suggest that under relatively physiological condi-
tions, the dosage compensation mechanism is quite accurate,
and results in target gene expression identical to that ob-
served in wild-type V. cholerae.
The analogous quorum-sensing circuit in V. harveyi pos-
sesses ﬁve homologous Qrr sRNAs, which function additively
to control quorum sensing. Speciﬁcally, deletion of one or
more of the qrr genes in V. harveyi results in intermediate
expression of quorum-sensing behaviours (Tu and Bassler,
2007). The quorum-sensing circuit of V. harveyi contains all
four feedback loops described in this work (Figure 1)
(Chatterjee et al, 1996; Tu et al, 2008), and hence it seems
paradoxical that the Qrrs function additively in one system
and redundantly in the other. Using the logic outlined in the
above section, we hypothesize that different degrees of LuxO
auto-repression in V. harveyi and V. cholerae could explain
this ﬁnding: If LuxO auto-repression is stronger in V. harveyi
than in V. cholerae, and thus, LuxO is conﬁned to a more
restricted concentration range in V. harveyi than in
V. cholerae, then dosage compensation in V. harveyi may
only be capable of accurately calibrating the Qrr sRNA levels
in response to very small ﬂuctuations in Qrrs. Thus, in
V. harveyi, accurate compensation does not occur even in
the absence of a single qrr gene, which would manifest in qrr
mutant phenotypes that appear additive.
The continued discovery of bacterial sRNAs now provides
many examples of multiple redundant sRNAs (Rudd, 1999;
Weilbacher et al, 2003; Wilderman et al, 2004; Guillier and
Gottesman, 2006; Kay et al, 2006; Urban and Vogel, 2008).
A few examples of sRNA dosage compensation have been
reported (Weilbacher et al, 2003; Kay et al, 2006), but in most
cases of redundant sRNAs, the issue of dosage compensation
has not been addressed. Hence, it is possible that dosage
compensation among homologous sRNAs is a common phe-
nomenon. We propose that the apparent requirement for
multiple, redundant sRNAs in many bacterial regulatory
circuits is coupled to their stoichiometric mode of action.
Coupled degradation of an sRNA with its mRNA target is
predicted to provide ultrasensitivity to sensory circuits and
also to enable prioritization of expression of multiple mRNA
targets (Lenz et al, 2004; Mitarai et al, 2007). This is because
if the rate of synthesis of an sRNA is even slightly higher than
the rate of synthesis of its mRNA partner, the sRNA can
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Reciprocally, if the rate of synthesis of an mRNA exceeds that
of the partner sRNA, then the mRNA can accumulate and the
sRNA disappears (Lenz et al, 2004). Similarly, if two mRNAs,
m1 and m2, have different afﬁnities for a shared sRNA
regulator, the mRNA with the highest afﬁnity for the sRNA,
say m1, will be degraded ﬁrst. This can effectively protect m2
from sRNA repression if all the sRNA is degraded along with
the m1 mRNA (Mitarai et al, 2007). These characteristics of
sRNA-mediated regulation make it crucial that sRNA produc-
tion is tightly controlled because a small change in the
production rate of the sRNA can dramatically affect the
expression of target mRNAs.
Variations in the amount of RNA produced from a single
gene over time or from cell to cell are caused by ﬂuctuations in
the amount, location, and activity of the necessary transcrip-
tion factors (extrinsic noise) as well as by inherent stochasti-
city in gene transcription (intrinsic noise) (Elowitz et al, 2002).
We propose that dosage compensation with multiple redun-
dant sRNAs keeps variations in sRNA levels to a minimum.
First, negative feedback regulation of any gene tends to reduce
ﬂuctuations in the gene product and maintain homoeostasis
(Seshasayee et al, 2006). Second, the inclusion of multiple
redundant genes in a negative feedback loop (i.e., dosage
compensation) has been shown theoretically to buffer down-
stream processes from variations arising from extrinsic noise
(Kafri et al, 2006). This can be understood intuitively in the
case of the Qrr sRNAs, as ﬂuctuations in the synthesis of one
qrr gene caused by variations in local concentrations of LuxO
and s
54-RNA polymerase holoenzyme will be counteracted by
altered expression of the additional qrr loci. If correct, the
increased accuracy in downstream gene expression stemming
from Qrr dosage compensation could explain how multiple
copies of the qrr genes have been selected and maintained
throughout the Vibrios.
Materials and methods
Bacterial strains and culture conditions
Vibrio cholerae strains used in this study are derivatives of El Tor
strain C6706str2 (Thelin and Taylor, 1996). E. coli strains S17-1lpir
(de Lorenzo and Timmis, 1994) and ElectroMAX DH10B (Invitro-
gen) were used for cloning and plasmid propagation. All strains
were grown in LB broth with aeration or on LB agar at 301C.
Antibiotics were used at the following concentrations (mg/ml):
ampicillin 200, kanamycin 100, chloramphenicol 10, polymyxin B
50, streptomycin 1000, and tetracycline 10.
DNA manipulations
All bacterial strains and plasmids used in this study are listed in
Supplementary Table S1. DNA manipulations were performed
according to Sambrook et al (Sambrook et al, 1989) unless otherwise
noted. Herculase polymerase (Stratagene) was used for PCRs in
cloning procedures, and Taq polymerase (Roche) was used for all
other PCRs. V. cholerae in-frame deletions were constructed by the
method of Skorupski and Taylor (1996). The lux transcriptional fusion
plasmids were constructed as reported (Lenz et al, 2004) and
introduced into V. cholerae by conjugation. The LuxO–GFP protein
fusion was constructed by cloning the luxO promoter sequence
including the ﬁrst 10 codons of the luxO ORF immediately upstream
of the gfp gene encoded on pCMW1 (Waters and Bassler, 2006) using
the SpeIa n dNheI restriction sites. This strategy resulted in plasmid
pSLS146. The luxO
AUCC mutation was introduced into pSLS146 by
Quickchange mutagenesis (Invitrogen) to generate pSLS152. An
oligonucleotide containing the  35 to þ1 sequence of the Ptac
promoter as well as the ﬁrst 20 nucleotides of the V. cholerae qrr4
gene was used to amplify qrr4f r o mV. cholerae C6706str2
chromosomal DNA in a PCR with a downstream primer complemen-
tary to the 30-end of qrr4. This Ptac-qrr4 construct was subsequently
cloned into pEVS141 (Dunn et al, 2006) using EcoRI and BamHI
restriction sites to generate pSLS155. E. coli strain SLS1277, which
carries V. cholerae qrr4 under the control of the chromosomal PBAD
promoter, was obtained by recombineering (Court et al, 2002).
Speciﬁcally, the araBAD genes of E. coli MG1655, which are
controlled by the PBAD promoter, were replaced by V. cholerae qrr4
linked to a kanamycin resistance cassette, and the desired recombi-
nant was obtained by selection for kanamycin resistance.
Bioluminescence assays
Bioluminescence was measured as described previously (Lenz et al,
2004). In all assays, overnight cultures were diluted 1000-fold and
grown to OD600¼0.1, at which point light production was
measured. Relative light units (RLU) are deﬁned as counts per
min per ml per OD600
 1 .
Northern blot analysis
Northern blots were performed as described (Martin et al, 1989;
Svenningsen et al, 2008) except that single-stranded DNA probes
were designed to hybridize to the entire length of the sRNAs and
were prepared by asymmetric PCRs. A common Qrr probe was
made to hybridize to the 32-bp region that is 100% conserved
among the four Qrr sRNAs. This probe was a radioactive-labelled
StarﬁreTM (Integrated DNA Technologies) oligonucleotide with the
sequence 50-ACTAACAACGTCAGTTGGCTAGGTGACCCT-30. For sin-
gle time-point northern blots, overnight cultures were diluted 1000-
fold and grown to OD600¼0.1, at which point total RNA was
collected as described (Svenningsen et al, 2008; Tu et al, 2008). For
Figure 4B, cultures were grown as described above, and rifampicin
was added at 100mg/ml when the cells reached OD600¼0.1.
Aliquots were collected every 30s after rifampicin addition,
combined with 0.2 volumes of stop solution (Papenfort et al,
2008), and snap-frozen in liquid nitrogen. Signal intensities were
quantiﬁed using an Alpha Innotech FluorChem image analysis
system.
Western blot analysis
Overnight cultures of the indicated V. cholerae strains were diluted
1000-fold in fresh LB medium. At OD600¼0.1 and 0.4, cells were
collected and resuspended in loading buffer (Henke and Bassler,
2004). Immunoblotting was performed as described (Henke and
Bassler, 2004). Membranes were exposed to polyclonal HapR
antiserum (Lenz et al, 2004).
Flow cytometry
Fluorescence of individual E. coli SLS1277 cells carrying pSLS146 or
pSLS152 that had been grown overnight with or without 0.4%
arabinose was measured on a Becton Dickinson FACS Aria cell
sorter. Data were analysed using the Becton Dickinson FACSDiva
software. GFP ﬂuorescence values reported here represent the mean
of 10000 individual cells.
Quantitative real-time PCR analysis
V. cholerae overnight cultures were diluted 1000-fold and grown to
OD600¼0.1 at which point total RNA was collected as described
above for northern blot analysis. Samples were treated with DNAse
I (Ambion). Puriﬁed RNAwas quantiﬁed by triplicate readings on a
NanoDrop
s ND-1000 Spectrophotometer (NanoDrop Technolo-
gies). cDNA synthesis and real-time PCR analysis were carried out
as described previously (Tu and Bassler, 2007). hfq was used as the
endogenous control. Primer sequences are available upon request.
Supplementary data
Supplementary data are available at The EMBO Journal Online
(http://www.embojournal.org).
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